HBM Healthcare Investments logo

HBM Healthcare Investments

Crunchbase
Pitchbook
Crunchbase

Deals on record

4

Common Fundraising Type

Series C

Curevo logo
Curevo

Biotechnology • Vaccines

Medicxi logo
Sanofi Ventures logo
RA Capital Management logo
OrbiMed logo

Curevo is a biotechnology company focused on developing vaccines with improved tolerability and accessibility, currently advancing a shingles vaccine called amezosvatein.

Series B
$110M
03/17/2025
Article
Numab Therapeutics logo
Numab Therapeutics

Biotech • Immunotherapies

RTW Investments logo
Novo Holdings logo
Octagon Capital Advisors logo
HBM Healthcare Investment logo

Numab Therapeutics is a biotech company that develops multi-specific antibody-based immunotherapies for inflammation and cancer.

Series C
$55M
01/10/2025
Article
Odyssey Therapeutics logo
Odyssey Therapeutics

Biotechnology • Immunomodulators

Woodline Partners logo
Walleye Capital logo
Leerink Partners logo
The Global BioAccess Fund logo

Odyssey Therapeutics is a biotech firm specializing in developing precision immunomodulators and oncology medicines, with plans to advance multiple therapeutic programs into clinical studies.

Series C
$101M
12/05/2023
Article
FORE Biotherapeutics logo
FORE Biotherapeutics

Precision Oncology • Clinical Development

SR One logo
Medicxi logo
Wellington Management logo
Samsung Securities logo

FORE Biotherapeutics is a precision oncology company that focuses on the clinical development of plixorafenib, a novel small-molecule inhibitor for treating BRAF-altered tumors.

Series D
$75M
08/23/2023
Article